The program is split into 15 tracks to provide informative sessions for delegates involved in all areas of the field of heart health which will cover a diverse array of topics.
Atherosclerotic renal artery disease
Onconephrology, Thrombotic microangiopathy, Nephritis, Nephrotoxicity, Nephronophthisis, Conventional dialysis replaced bio artificial technologies
Stem cell
Bioengineering approaches
Nanotechnology for implantable kidneys
Regenerative therapies
Laparoscopic Nephrectomy
Neobladder Construction
Robotic-Assisted Laparoscopic Pyeloplasty
Wearable artificial kidney
Coronavirus might target kidney cells
Too little oxygen can cause kidneys to malfunction
Cytokine storms can destroy kidney tissue
COVID-19 causes blood clots that might clog the kidneys
Hemodialysis Nurse, Care for kidney ailments, vascular access coordinator, Peritoneal dialysis Nurse, Transplant facilitator, Clinical therapeutic specialist expert
Hemodialysis
Peritoneal dialysis
Continuous renal replacement therapy
Perioperative Nursing
Are low or very low-protein diets still useful and attractive treatment in CKD?
Ketogenic diet: a new tool to improve renal cyst growth in ADPKD.
Role of kidney proximal tubules to balance nutrient and uremic toxins levels.
End-Stage Renal Diseases, Acute Kidney Injury, Glomerulonephritis, lupus nephritis, Renal Cancer, Renal Necrosis, Nephrosclerosis, Reflux nephropathy
Azotemia, Kidney Failure, renal osteodystrophy, polycystic kidney disease
Alport Syndrome
Bartter Syndrome
Cystic Diseases of the Kidney
Horseshoe Kidney
Medullary Sponge Kidney
Megaureter and Other Congenital Ureteral Anomalies
Renal ultrasonography
Insertion of Peritoneal Dialysis catheters
Insertion of Tunneled Dialysis Catheters
Intravenous Urography (IVU)
Renal scintigraphy
Renal arteriography
Computed tomography (CT scan or CAT scan), Medical ultrasonography
Retrograde urography
Percutaneous antegrade urography
Radionuclide scanning
Blood test for GFR
Urine Test for Albumin
Biopsy
Medication
Diet and lifestyle changes
End-Stage Treatment
Renal replacement therapies
Type-4 cardiorenal syndrome
Renovascular Hypertension
Diabetic Nephropathy, Ischemic nephropathy, focal segmental glomerulosclerosis
HTN nephrosclerosis
Diabetic Glomerulosclerosis
Glycemic Control & Diabetic Ketoacidosis
Renal cell carcinoma, Kidney Neoplasms
Chemotherapeutic agents, such as platinum-based compounds, ifosfamide, anti-VEGF agents, tyrosine kinase inhibitors, methotrexate, and several other drugs
Management of paraneoplastic nephrological syndromes and contrast-induced nephropathy
Mesenchymal stem cells
Induced pluripotent stem cell
Pluripotent Stem Cell Therapy
Adult Stem Cell Therapy
Directed Differentiation of Induced Pluripotent Stem Cells and Embryonic Stem Cells into Kidney Cells
Blastocyst Complementation
Adult Kidney Stem/Progenitor Cell Reconstitution
Decellularized Cadaveric Scaffold
Embryonic Organ Transplantation
Tissue Engineering of a Bioartificial Kidney: Renal Tubule Assist Device
Use of a Nephrogenic Niche for Growing Xenoembryos
Intracorporeal Lithotripsy
Laser-Induced Breakdown Spectroscopy
Laser lithotripsy
Shock wave lithotripsy
Ureteroscopy
Percutaneous nephrolithotomy or percutaneous nephrolithotripsy
low-level laser therapy
Asymmetric Dimethylarginine (ADMA)
Symmetric Dimethylarginine (SDMA)
Uromodulin
Kidney Injury Molecule-1 (KIM-1)
Neutrophil Gelatinase-Associated Lipocalin (NGAL)
miRNA, ncRNA, lncRNA and lincRNA Biomarkers
Proteomic and Metabolomic Biomarkers